We are live on ! Find out more
BOLD

Audentes Therapeutics, Inc
BOLD

Delisted

BOLD was delisted on the 14th of January, 2020.

Back to rankings

49 hedge funds and large institutions have $272M invested in Audentes Therapeutics, Inc in 2016 Q3 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+49
Holders Change %
–
% of All Funds
1.31%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
49
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$72.9M
2
VVM
Versant Venture Management
California
+$27.4M
3
DM
Deerfield Management
New York
+$21.3M
4
RG
Redmile Group
California
+$13.9M
5
RCM
RA Capital Management
Massachusetts
+$10.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Victory Capital Management
26
Victory Capital Management
Texas
$641K +$546K +36,000 New
State Street
27
State Street
Massachusetts
$632K +$539K +35,500 New
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$585K +$499K +32,870 New
BlackRock
29
BlackRock
New York
$519K +$442K +29,155 New
Bank of America
30
Bank of America
North Carolina
$358K +$305K +20,106 New
RI
31
RTW Investments
New York
$356K +$304K +20,000 New
LCM
32
Laurion Capital Management
New York
$267K +$228K +15,000 New
VM
33
VHCP Management
New York
$267K +$228K +15,000 New
Geode Capital Management
34
Geode Capital Management
Massachusetts
$253K +$216K +14,229 New
BIM
35
BlackRock Investment Management
Delaware
$253K +$216K +14,233 New
Goldman Sachs
36
Goldman Sachs
New York
$224K +$191K +12,604 New
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$217K +$185K +12,200 New
TD Asset Management
38
TD Asset Management
Ontario, Canada
$191K +$162K +10,700 New
BIT
39
BlackRock Institutional Trust
California
$146K +$124K +8,189 New
PA
40
Perceptive Advisors
New York
$134K +$114K +7,500 New
TA
41
Teachers Advisors
New York
$108K +$92.3K +6,085 New
SO
42
STRS Ohio
Ohio
$32K +$27.3K +1,800 New
UBS Group
43
UBS Group
Switzerland
$25K +$21.2K +1,394 New
Deutsche Bank
44
Deutsche Bank
Germany
$17K +$14.6K +962 New
Citigroup
45
Citigroup
New York
$8K +$7.12K +469 New
TRCT
46
Tower Research Capital (TRC)
New York
$7K +$5.62K +370 New
CCA
47
Catalyst Capital Advisors
New York
$4K +$3.49K +230 New
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$3.67K +$3.13K +206 New
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$2K +$1.52K +100 New
1
2

BOLD Hedge Fund Activity: Q3 2016 in Review

49 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Audentes Therapeutics, Inc (BOLD) for Q3 2016, worth a combined $272M.

Buyers outnumbered sellers: 49 funds opened new BOLD positions and 0 closed out — a net gain of 49 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $72.9M.

  • 49 institutional investors held Audentes Therapeutics, Inc (BOLD) as of Q3 2016, up from 0 in Q2 2016.
  • Funds reported $272M of Audentes Therapeutics, Inc stock for Q3 2016.
  • 49 funds opened new Audentes Therapeutics, Inc positions in Q3 2016 and 0 closed out, a net change of +49 holders.
  • The largest Audentes Therapeutics, Inc buyer in Q3 2016 was OrbiMed, an estimated $72.9M added.

Based on aggregated 13F filings for Q3 2016.